ConductScience.org, home

Paper31979032

Candida albicans Antifungal Resistance and Tolerance in Bloodstream Infections: The Triad Yeast-Host-Antifungal.

Costa-de-Oliveira S and 1 other. Microorganisms, 2020. Cited by 151 papers, by iCite.

Cite this record

ConductScience Library. Candida albicans Antifungal Resistance and Tolerance in Bloodstream Infections: The Triad Yeast-Host-Antifungal. Papers, record 31979032. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31979032

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Candida albicans Antifungal Resistance and Tolerance in Bloodstream Infections: The Triad Yeast-Host-Antifungal.
PubMed
Journal
Microorganisms
PubMed
Year
2020
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
151
iCite
Relative citation ratio, by iCite
11.2
iCite
Revised in PubMed
2024-07-27
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Costa-de-Oliveira SSofia
2Rodrigues AGAcácio G

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References170

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117660216Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis.Ann Rheum Dis2008https://conductscience.org/library/papers/17660216PubMed
212753189Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence.Mol Microbiol2003https://conductscience.org/library/papers/12753189PubMed
330348662FK506 Resistance of Saccharomyces cerevisiae Pdr5 and Candida albicans Cdr1 Involves Mutations in the Transmembrane Domains and Extracellular Loops.Antimicrob Agents Chemother2019https://conductscience.org/library/papers/30348662PubMed
419109335Comparative pharmacodynamic interaction analysis between ciprofloxacin, moxifloxacin and levofloxacin and antifungal agents against Candida albicans and Aspergillus fumigatus.J Antimicrob Chemother2009https://conductscience.org/library/papers/19109335PubMed
519656781The alternative oxidase of Candida albicans causes reduced fluconazole susceptibility.J Antimicrob Chemother2009https://conductscience.org/library/papers/19656781PubMed
624668706Candidemia in intensive care unit: a nationwide prospective observational survey (GISIA-3 study) and review of the European literature from 2000 through 2013.Eur Rev Med Pharmacol Sci2014https://conductscience.org/library/papers/24668706PubMed
710543759The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.Antimicrob Agents Chemother1999https://conductscience.org/library/papers/10543759PubMed
817569573Resistance to echinocandin-class antifungal drugs.Drug Resist Updat2007https://conductscience.org/library/papers/17569573PubMed
926567280Role of Echinocandins in Fungal Biofilm-Related Disease: Vascular Catheter-Related Infections, Immunomodulation, and Mucosal Surfaces.Clin Infect Dis2015https://conductscience.org/library/papers/26567280PubMed
1024270071Epidemiology of candidaemia and invasive candidiasis. A changing face.Rev Iberoam Micol2014https://conductscience.org/library/papers/24270071PubMed
1129304214Biofilms and beyond: expanding echinocandin utility.J Antimicrob Chemother2018https://conductscience.org/library/papers/29304214PubMed
129037636Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU.Intensive Care Med1997https://conductscience.org/library/papers/9037636PubMed
1321307753Candidemia in burn patients: figures and facts.J Trauma2011https://conductscience.org/library/papers/21307753PubMed
147541044Interaction of FKBP12-FK506 with calcineurin A at the B subunit-binding domain.J Biol Chem1995https://conductscience.org/library/papers/7541044PubMed
1517983269The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans.PLoS Pathog2007https://conductscience.org/library/papers/17983269PubMed
1623740727In vitro activities of isavuconazole and comparator antifungal agents tested against a global collection of opportunistic yeasts and molds.J Clin Microbiol2013https://conductscience.org/library/papers/23740727PubMed
1722203603Reshuffling of Aspergillus fumigatus cell wall components chitin and β-glucan under the influence of caspofungin or nikkomycin Z alone or in combination.Antimicrob Agents Chemother2012https://conductscience.org/library/papers/22203603PubMed
1830895218Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997-2016.Open Forum Infect Dis2019https://conductscience.org/library/papers/30895218PubMed
1919191635Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.Clin Infect Dis2009https://conductscience.org/library/papers/19191635PubMed
2019541532Hidden killers: persistence of opportunistic fungal pathogens in the human host.Curr Opin Microbiol2009https://conductscience.org/library/papers/19541532PubMed

See all 170 referencesDownload CSV of references

Cited by110

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 151 citations.

PMIDTitleJournalYearIn PapersSource
42930756Adapting to the Host: Physiological Responses, Cell Wall Remodeling, and Persistence in Non-albicans Candida Species.J Fungi (Basel)2026https://conductscience.org/library/papers/42930756PubMed
42920537Phenotypic and metabolic characterization of an ADH2 deletion mutant associated with reduced fluconazole susceptibility in Candida albicans.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/42920537PubMed
42902047Assessment of Candida attributes under in vitro repeated exposure to hydrogen peroxide.Int Microbiol2026https://conductscience.org/library/papers/42902047PubMed
42807021
Large-scale virtual screening of 17,967 IMPPAT phytochemicals identifies multiple CDR1 binders and reveals Apigenin-7-O-glucuronide as a putative CDR1-GSC1 dual-target lead against Candida albicans with initial in-vitro evidence.
Front Cell Infect Microbiol2026https://conductscience.org/library/papers/42807021PubMed
42794569WHO Critical Priority Fungi: A Comprehensive Review of Antifungal Resistance, Emerging Therapeutic Strategies, and the Potential of Antifungal Peptides.Int J Mol Sci2026https://conductscience.org/library/papers/42794569PubMed
42707095Microbial community structure in tinea corporis and antifungal activity of Lactiplantibacillus plantarum YM-4-3 strain.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/42707095PubMed
42598379First Case of Candidemia With Fluconazole-Resistant Candida albicans and Y132H Mutations in ERG11 Gene From Pakistan.Case Rep Infect Dis2026https://conductscience.org/library/papers/42598379PubMed
42471448Synthetic Cinnamyl Acetate as a Candidate Inhibitor of Candida albicans Biofilms with an Adhesin-Associated Anti-Adhesion Phenotype: Evidence from Molecular Docking and Antifungal Assays.Curr Microbiol2026https://conductscience.org/library/papers/42471448PubMed
42436744In Vivo Evaluation of Efficacy and Toxicity of Bioinspired Peptides With Antimicrobial Properties Against Fungal Infection in Galleria mellonella Larvae.Int J Microbiol2026https://conductscience.org/library/papers/42436744PubMed
42409910In vitro evaluation of Curcuma longa extract for antifungal, antibiofilm, and synergistic activity against Candida spp.Sci Rep2026https://conductscience.org/library/papers/42409910PubMed
42205484In silico identification of isosilybin a targeting squalene epoxidase as an antifungal adjuvant with in vitro validation against azole-resistant Candida and emerging yeasts.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/42205484PubMed
42197494Infectious Spondylodiscitis of Bacterial Causes in Adults: Epidemiology, Pathophysiology, Diagnostic and Treatment Challenges.Microorganisms2026https://conductscience.org/library/papers/42197494PubMed
42015072Candida urinary tract infections, antifungal susceptibility and factors associated with candiduria among pregnant women seeking antenatal care at Murang'a County Referral Hospital, Kenya.BMC Pregnancy Childbirth2026https://conductscience.org/library/papers/42015072PubMed
41813782Povidone iodine demonstrates strong efficacy in reducing Candida biofilm in an in vitro fungal prosthetic infection.Sci Rep2026https://conductscience.org/library/papers/41813782PubMed
41696452Caspofungin enhances antifungal immunity in human blood through transcriptional reprogramming.Microlife2026https://conductscience.org/library/papers/41696452PubMed
41688542Candida albicans infection suppresses lipopolysaccharide or Pseudomonas aeruginosa stimulated murine bone marrow derived macrophage (BMDM) responses.Sci Rep2026https://conductscience.org/library/papers/41688542PubMed
41596273Catechin Augments the Antifungal Efficacy of Fluconazole Against Candida parapsilosis.Int J Mol Sci2026https://conductscience.org/library/papers/41596273PubMed
41573869An optimized protocol for Candida albicans infection in Schmidtea mediterranea to study fungal pathogenesis and host defense.bioRxiv2025https://conductscience.org/library/papers/41573869PubMed
41471177Epidemiology of Fungal Bloodstream Infections and Antifungal Susceptibility in a Tertiary Care Hospital in Riyadh, Saudi Arabia: A Rare Candida Co-Infection Case.Pathogens2025https://conductscience.org/library/papers/41471177PubMed
41355988Overcoming antifungal resistance in Candida albicans via RNA interference: a therapeutic perspective.Front Cell Infect Microbiol2025https://conductscience.org/library/papers/41355988PubMed

See all 110 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243NCBI Gene
CYP51A11595PubTator's text mininghttps://conductscience.org/library/genes/1595NCBI Gene
PGP283871PubTator's text mininghttps://conductscience.org/library/genes/283871NCBI Gene
PPP3R15534PubTator's text mininghttps://conductscience.org/library/genes/5534NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31979032

GET https://conductscience.org/api/papers/v1/31979032/references?page=2